• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危患者为何会发生或不发生冠状动脉疾病?来自CAPIRE研究的代谢学见解。

Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study.

作者信息

Deidda Martino, Noto Antonio, Cadeddu Dessalvi Christian, Andreini Daniele, Andreotti Felicita, Ferrannini Eleuterio, Latini Roberto, Maggioni Aldo P, Magnoni Marco, Mercuro Giuseppe

机构信息

Department of Medical Sciences and Public Health, University of Cagliari, 09042 Monserrato, Italy.

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.

出版信息

Metabolites. 2022 Jan 27;12(2):123. doi: 10.3390/metabo12020123.

DOI:10.3390/metabo12020123
PMID:35208197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8876355/
Abstract

Traditional cardiovascular (CV) risk factors (RFs) and coronary artery disease (CAD) do not always show a direct correlation. We investigated the metabolic differences in a cohort of patients with a high CV risk profile who developed, or did not develop, among those enrolled in the Coronary Atherosclerosis in Outlier Subjects: Protective and Novel Individual Risk Factors Evaluation (CAPIRE) study. We studied 112 subjects with a high CV risk profile, subdividing them according to the presence (CAD/High-RFs) or absence of CAD (No-CAD/High-RFs), assessed by computed tomography angiography. The metabolic differences between the two groups were identified by gas chromatography-mass spectrometry. Characteristic patterns and specific metabolites emerged for each of the two phenotypic groups: high concentrations of pyruvic acid, pipecolic acid, p-cresol, 3-aminoisobutyric acid, isoleucine, glyceric acid, lactic acid, sucrose, phosphoric acid, trimethylamine-N-oxide, 3-hydroxy-3-methylglutaric acid, erythritol, 3-hydroxybutyric acid, glucose, leucine, and glutamic acid; and low concentrations of cholesterol, hypoxanthine, glycerol-3-P, and cysteine in the CAD/High-RFs group vs the No-CAD/High-RFs group. Our results show the existence of different metabolic profiles between patients who develop CAD and those who do not, despite comparable high CV risk profiles. A specific cluster of metabolites, rather than a single marker, appears to be able to identify novel predisposing or protective mechanisms towards CAD beyond classic CVRFs.

摘要

传统心血管(CV)危险因素(RFs)与冠状动脉疾病(CAD)并不总是呈现直接关联。我们在“异常受试者冠状动脉粥样硬化:保护性和新型个体危险因素评估(CAPIRE)研究”中,对一组具有高CV风险特征且发生或未发生CAD的患者队列中的代谢差异进行了调查。我们研究了112名具有高CV风险特征的受试者,根据计算机断层扫描血管造影评估的CAD存在情况(CAD/高RFs)或不存在情况(无CAD/高RFs)将他们进行细分。通过气相色谱 - 质谱法确定两组之间的代谢差异。两个表型组各自出现了特征模式和特定代谢物:CAD/高RFs组相对于无CAD/高RFs组,丙酮酸、哌啶酸、对甲酚、3 - 氨基异丁酸、异亮氨酸、甘油酸、乳酸、蔗糖、磷酸、氧化三甲胺、3 - 羟基 - 3 - 甲基戊二酸、赤藓糖醇、3 - 羟基丁酸、葡萄糖、亮氨酸和谷氨酸浓度较高;胆固醇、次黄嘌呤、甘油 - 3 - 磷酸和半胱氨酸浓度较低。我们的结果表明,尽管CV风险特征相当,但发生CAD的患者与未发生CAD的患者之间存在不同的代谢谱。一组特定的代谢物,而非单一标志物,似乎能够识别出超越经典CV危险因素的针对CAD的新的易感或保护机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74e5/8876355/7318090eaffd/metabolites-12-00123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74e5/8876355/7318090eaffd/metabolites-12-00123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74e5/8876355/7318090eaffd/metabolites-12-00123-g001.jpg

相似文献

1
Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study.高危患者为何会发生或不发生冠状动脉疾病?来自CAPIRE研究的代谢学见解。
Metabolites. 2022 Jan 27;12(2):123. doi: 10.3390/metabo12020123.
2
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study.冠状动脉粥样硬化、心血管风险的代谢组学相关性,或者两者都没有。2×2 表型 CAPIRE 研究的结果。
Int J Cardiol. 2021 Aug 1;336:14-21. doi: 10.1016/j.ijcard.2021.05.033. Epub 2021 May 20.
3
Coronary atherosclerosis in outlier subjects at the opposite extremes of traditional risk factors: Rationale and preliminary results of the Coronary Atherosclerosis in outlier subjects: Protective and novel Individual Risk factors Evaluation (CAPIRE) study.传统危险因素处于相反极端的异常受试者中的冠状动脉粥样硬化:异常受试者冠状动脉粥样硬化:保护性和新型个体危险因素评估(CAPIRE)研究的原理与初步结果
Am Heart J. 2016 Mar;173:18-26. doi: 10.1016/j.ahj.2015.11.017. Epub 2015 Dec 17.
4
Coronary Plaque Features on CTA Can Identify Patients at Increased Risk of Cardiovascular Events.CTA 冠脉斑块特征可识别心血管事件风险增加的患者。
JACC Cardiovasc Imaging. 2020 Aug;13(8):1704-1717. doi: 10.1016/j.jcmg.2019.06.019. Epub 2019 Aug 14.
5
Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE Study.骨桥蛋白作为心血管疾病低风险患者的候选生物标志物:来自 CAPIRE 研究的新见解。
Cells. 2022 Feb 15;11(4):669. doi: 10.3390/cells11040669.
6
Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical events.载脂蛋白 AI 对冠心病患者的预测价值:与冠状动脉斑块特征及临床事件的关系。
Ann Med. 2022 Dec;54(1):1036-1046. doi: 10.1080/07853890.2022.2063374.
7
Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors.甘油三酯葡萄糖指数是预测无传统危险因素的亚临床冠状动脉疾病的有用标志物。
Lipids Health Dis. 2020 Jan 14;19(1):7. doi: 10.1186/s12944-020-1187-0.
8
Usefulness of High-Sensitivity Cardiac Troponin T for the Identification of Outlier Patients With Diffuse Coronary Atherosclerosis and Low-Risk Factors.高敏心肌肌钙蛋白T用于识别弥漫性冠状动脉粥样硬化和低风险因素的异常患者的效用。
Am J Cardiol. 2016 May 1;117(9):1397-404. doi: 10.1016/j.amjcard.2016.02.002. Epub 2016 Feb 17.
9
Associations of the serum metabolite profile with a healthy Nordic diet and risk of coronary artery disease.血清代谢物谱与健康的北欧饮食和冠心病风险的关联。
Clin Nutr. 2021 May;40(5):3250-3262. doi: 10.1016/j.clnu.2020.10.051. Epub 2020 Oct 31.
10
Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans.人类心血管风险与冠状动脉疾病的差异蛋白质组学
Front Cardiovasc Med. 2022 Feb 4;8:790289. doi: 10.3389/fcvm.2021.790289. eCollection 2021.

引用本文的文献

1
Sweeteners: erythritol, xylitol and cardiovascular risk-friend or foe?甜味剂:赤藓糖醇、木糖醇与心血管风险——是友还是敌?
Cardiovasc Res. 2025 Aug 14;121(9):1319-1329. doi: 10.1093/cvr/cvaf091.
2
Nuclear Magnetic Resonance (NMR)-Based Lipidomics Reveal the Association of Altered Red Blood Cell (RBC) Membrane Lipidome with the Presence and the Severity of Coronary Artery Stenosis.基于核磁共振(NMR)的脂质组学揭示了红细胞(RBC)膜脂质组改变与冠状动脉狭窄的存在及严重程度之间的关联。
Molecules. 2024 Dec 26;30(1):36. doi: 10.3390/molecules30010036.
3
Plasma levels of polyols erythritol, mannitol, and sorbitol and incident coronary heart disease among women.

本文引用的文献

1
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study.冠状动脉粥样硬化、心血管风险的代谢组学相关性,或者两者都没有。2×2 表型 CAPIRE 研究的结果。
Int J Cardiol. 2021 Aug 1;336:14-21. doi: 10.1016/j.ijcard.2021.05.033. Epub 2021 May 20.
2
Unconjugated p-cresol activates macrophage macropinocytosis leading to increased LDL uptake.未结合的对甲酚激活巨噬细胞巨胞饮作用,导致 LDL 摄取增加。
JCI Insight. 2021 Jun 8;6(11):144410. doi: 10.1172/jci.insight.144410.
3
Gut Microbiota and Cardiovascular Disease.
女性血浆中多元醇(赤藓糖醇、甘露醇和山梨醇)水平与冠心病发病情况
Eur J Prev Cardiol. 2025 Apr 2;32(5):404-414. doi: 10.1093/eurjpc/zwae288.
4
Plasma Metabolic Profiling and Multiclass Diagnostic Model Development for Stable Angina Pectoris and Acute Myocardial Infarction.稳定型心绞痛和急性心肌梗死的血浆代谢谱分析及多类诊断模型开发
ACS Omega. 2024 Mar 26;9(14):16322-16333. doi: 10.1021/acsomega.3c10474. eCollection 2024 Apr 9.
5
IgG N-Glycosylation Is Altered in Coronary Artery Disease.IgG N-糖基化在冠状动脉疾病中发生改变。
Biomolecules. 2023 Feb 16;13(2):375. doi: 10.3390/biom13020375.
肠道微生物群与心血管疾病。
Circ Res. 2020 Jul 31;127(4):553-570. doi: 10.1161/CIRCRESAHA.120.316242. Epub 2020 Jul 30.
4
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.肠道微生物组与冠状动脉疾病和心力衰竭:现有知识和未来方向。
EBioMedicine. 2020 Feb;52:102649. doi: 10.1016/j.ebiom.2020.102649. Epub 2020 Feb 12.
5
Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies.赖氨酸代谢物与 PREDIMED 研究中 2 型糖尿病和心血管疾病的风险:两项病例-队列研究的结果。
Cardiovasc Diabetol. 2019 Nov 13;18(1):151. doi: 10.1186/s12933-019-0958-2.
6
Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease.三甲胺 N-氧化物(TMAO)可预测外周动脉疾病的心血管死亡率。
Sci Rep. 2019 Oct 30;9(1):15580. doi: 10.1038/s41598-019-52082-z.
7
[The level of circulating humanin in patients with ischemic heart disease.].[缺血性心脏病患者循环中人胰岛素的水平。]
Klin Lab Diagn. 2018;63(8):466-470. doi: 10.18821/0869-2084-2018-63-8-466-470.
8
The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense.衰竭的心脏利用 3-羟基丁酸作为代谢应激防御。
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.124079.
9
Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.黄素单加氧酶 3 是机体三甲基胺 N-氧化物生成途径中的主要肝酶,可调节血小板反应性和血栓形成风险。
J Thromb Haemost. 2018 Sep;16(9):1857-1872. doi: 10.1111/jth.14234. Epub 2018 Aug 9.
10
Specific Amino Acids Affect Cardiovascular Diseases and Atherogenesis via Protection against Macrophage Foam Cell Formation: Review Article.特定氨基酸通过防止巨噬细胞泡沫细胞形成影响心血管疾病和动脉粥样硬化发生:综述文章
Rambam Maimonides Med J. 2018 Jul 30;9(3):e0022. doi: 10.5041/RMMJ.10337.